Top Story

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014

Read the Perspective from Neeraj Agarwal, MD

Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related neuroendocrine prostate cancer, according to study results.

Survival after diagnosis of neuroendocrine prostate cancer was associated with treatment type and the number of organs with metastatic disease, results also showed.

Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had…
Ruth Etzioni, MD In the Journals

PSA increase after radical prostatectomy may not predict recurrence

November 18, 2014
Among patients with prostate cancer who have undergone radical prostatectomy, increases in PSA may not be predictive of progression to metastatic disease in the…
In the Journals

Radium-223 dichloride effective in CRPC, regardless of prior docetaxel

November 6, 2014
Radium Ra 223 dichloride appeared safe and effective in patients with castration-resistant prostate cancer and symptomatic bone metastases regardless of whether they…
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
Ruth Etzioni, MD In the Journals

PSA increase after radical prostatectomy may not predict recurrence

November 18, 2014
Among patients with prostate cancer who have undergone radical prostatectomy, increases in PSA may not be predictive of progression to metastatic…
In the Journals

Radium-223 dichloride effective in CRPC, regardless of prior docetaxel

November 6, 2014
Radium Ra 223 dichloride appeared safe and effective in patients with castration-resistant prostate cancer and symptomatic bone metastases regardless…
In the Journals

ADT raised risk for cardiac death in men with prostate cancer

October 29, 2014
In men receiving treatment for prostate cancer, androgen deprivation therapy was associated with excess risk for cardiac-related death in those with…
In the Journals

Tumor characteristics influenced impact of adjuvant radiotherapy in prostate cancer

October 23, 2014
Tumor characteristics considerably influenced the impact of adjuvant radiotherapy on survival outcomes in patients with node-positive prostate…
Male pattern baldness increased risk for aggressive prostate cancer In the Journals

Male pattern baldness increased risk for aggressive prostate cancer

October 17, 2014
Men who exhibited frontal plus moderate vertex baldness by age 45 years were at increased risk for developing aggressive prostate cancer, according…
Anja Mehnert, PhD In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
In the JournalsPerspective

Increased prostate, pancreatic cancer risks among BRCA mutation carriers support additional screening

October 3, 2014
Individuals with BRCA2 mutations demonstrated significantly higher risks for pancreatic cancer and prostate cancer than noncarriers, according to…
Watchful waiting may not benefit black men with low-grade prostate cancer Meeting News Coverage

Watchful waiting may not benefit black men with low-grade prostate cancer

October 3, 2014
In patients with low-grade prostate cancer, black race was associated with poorer outcomes in terms of freedom from biochemical failure after radical…
More Headlines »
morganatic-roan
morganatic-roan